Bank Hapoalim Bm Abb Vie Inc. Transaction History

Bank Hapoalim Bm

$660 Million
Q3 2024

A detailed history of Bank Hapoalim Bm transactions in Abb Vie Inc. stock. As of the latest transaction made, Bank Hapoalim Bm holds 19,445 shares of ABBV stock, worth $3.56 Million. This represents 0.58% of its overall portfolio holdings.

Number of Shares

19,445

Previous 19,954 2.55%

Holding current value

$3.56 Million

Previous $3.42 Million 12.18%

% of portfolio

0.58%

Previous 0.48%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 28, 2024	SELL	$163.84 - $199.33 $83,394 - $101,458	-509 Reduced 2.55%	19,445 $3.84 Million
Q2 2024 Jul 23, 2024	SELL	$154.79 - $180.76 $334,191 - $390,260	-2,159 Reduced 9.76%	19,954 $3.42 Million
Q1 2024 May 01, 2024	SELL	$159.82 - $182.1 $117,947 - $134,389	-738 Reduced 3.23%	22,113 $4.03 Million
Q4 2023 Jan 22, 2024	SELL	$137.6 - $154.97 $114,208 - $128,625	-830 Reduced 3.5%	22,851 $3.54 Million
Q3 2023 Oct 24, 2023	SELL	$133.59 - $154.65 $889,575 - $1.03 Million	-6,659 Reduced 21.95%	23,681 $3.53 Million
Q2 2023 Jul 26, 2023	SELL	$132.51 - $164.9 $480,348 - $597,762	-3,625 Reduced 10.67%	30,340 $4.09 Million
Q1 2023 Apr 25, 2023	SELL	$144.61 - $166.54 $744,018 - $856,848	-5,145 Reduced 13.16%	33,965 $5.41 Million
Q4 2022 Jan 26, 2023	SELL	$138.31 - $165.87 $117,010 - $140,326	-846 Reduced 2.12%	39,110 $6.32 Million
Q3 2022 Nov 08, 2022	SELL	$134.21 - $153.93 $161,723 - $185,485	-1,205 Reduced 2.93%	39,956 $5.36 Million
Q2 2022 Jul 27, 2022	SELL	$137.62 - $174.96 $126,610 - $160,963	-920 Reduced 2.19%	41,161 $6.3 Million
Q1 2022 Apr 28, 2022	BUY	$131.98 - $163.75 $1.24 Million - $1.54 Million	9,421 Added 28.85%	42,081 $6.82 Million
Q4 2021 Feb 04, 2022	BUY	$107.43 - $135.93 $288,449 - $364,972	2,685 Added 8.96%	32,660 $4.42 Million
Q3 2021 Oct 27, 2021	BUY	$106.4 - $120.78 $82,992 - $94,208	780 Added 2.67%	29,975 $3.23 Million
Q2 2021 Aug 05, 2021	SELL	$105.21 - $117.21 $84,273 - $93,885	-801 Reduced 2.67%	29,195 $3.29 Million
Q1 2021 Apr 26, 2021	SELL	$102.3 - $112.62 $6,649 - $7,320	-65 Reduced 0.22%	29,996 $3.25 Million
Q4 2020 Feb 03, 2021	SELL	$80.49 - $108.67 $45,074 - $60,855	-560 Reduced 1.83%	30,061 $3.22 Million
Q3 2020 Nov 12, 2020	SELL	$85.91 - $100.83 $144,242 - $169,293	-1,679 Reduced 5.2%	30,621 $2.68 Million
Q2 2020 Aug 04, 2020	SELL	$73.37 - $98.18 $12,106 - $16,199	-165 Reduced 0.51%	32,300 $3.17 Million
Q1 2020 May 06, 2020	BUY	$64.5 - $97.79 $311,535 - $472,325	4,830 Added 17.48%	32,465 $2.47 Million
Q4 2019 Feb 03, 2020	BUY	$72.13 - $90.25 $34,983 - $43,771	485 Added 1.79%	27,635 $2.45 Million
Q3 2019 Nov 01, 2019	BUY	$62.98 - $75.72 $542,257 - $651,949	8,610 Added 46.44%	27,150 $2.03 Million
Q2 2019 Aug 06, 2019	BUY	$65.7 - $83.98 $204,327 - $261,177	3,110 Added 20.16%	18,540 $1.35 Million
Q1 2019 May 07, 2019	BUY	$77.14 - $90.79 $143,866 - $169,323	1,865 Added 13.75%	15,430 $1.24 Million
Q4 2018 Feb 11, 2019	BUY	$77.85 - $96.01 $126,895 - $156,496	1,630 Added 13.66%	13,565 $1.25 Million
Q3 2018 Nov 08, 2018	BUY	$88.91 - $98.84 $452,996 - $503,589	5,095 Added 74.49%	11,935 $1.13 Million
Q2 2018 Jul 24, 2018	BUY	$89.78 - $106.23 $120,305 - $142,348	1,340 Added 24.36%	6,840 $634,000
Q1 2018 Apr 30, 2018	SELL	$92.01 - $123.21 $42,784 - $57,292	-465 Reduced 7.8%	5,500 $521,000
Q4 2017 Feb 05, 2018	BUY	$89.56 - $98.21 $48,810 - $53,524	545 Added 10.06%	5,965 $0
Q3 2017 Nov 07, 2017	SELL	$69.85 - $89.22 $17,462 - $22,305	-250 Reduced 4.41%	5,420 $482,000
Q2 2017 Aug 11, 2017	BUY	N/A	5,670	5,670 $411,000

Others Institutions Holding ABBV

# of Institutions

3,849

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $324B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Hapoalim Bm, based on Form 13F filings with the SEC.

News

Stay updated on Bank Hapoalim Bm with notifications on news.

Account